Evidence map›Paper›PMID 29074987›Full record

ArticleNature communications2017

Adaptive artificial evolution of droplet protocells in a 3D-printed fluidic chemorobotic platform with configurable environments.

Juan Manuel Parrilla-Gutierrez, Soichiro Tsuda, Jonathan Grizou, James Taylor, Alon Henson, Leroy Cronin

Abstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juan Manuel Parrilla-GutierrezWestCHEM, School of Chemistry, The University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
Soichiro TsudaWestCHEM, School of Chemistry, The University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
Jonathan GrizouWestCHEM, School of Chemistry, The University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
James TaylorWestCHEM, School of Chemistry, The University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.ORCID http://orcid.org/0000-0002-3162-1972
Alon HensonWestCHEM, School of Chemistry, The University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
Leroy CroninWestCHEM, School of Chemistry, The University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK. Lee.Cronin@glasgow.ac.uk.ORCID http://orcid.org/0000-0001-8035-5757

Funding

Biotechnology and Biological Sciences Research Council BB/M011267/1
6 · The paper itself

Abstract

Evolution via natural selection is governed by the persistence and propagation of living things in an environment. The environment is important since it enabled life to emerge, and shapes evolution today. Although evolution has been widely studied in a variety of fields from biology to computer science, still little is known about the impact of environmental changes on an artificial chemical evolving system outside of computer simulations. Here we develop a fully automated 3D-printed chemorobotic fluidic system that is able to generate and select droplet protocells in real time while changing the surroundings where they undergo artificial evolution. The system is produced using rapid prototyping and explicitly introduces programmable environments as an experimental variable. Our results show that the environment not only acts as an active selector over the genotypes, but also enhances the capacity for individual genotypes to undergo adaptation in response to environmental pressures.

Identifiers

PMID29074987
PMCPMC5658334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.